Aerpio Pharmaceuticals Inc (ARPO) Stock Analyst Ratings
USA - NASDAQ:ARPO -
2.2
-0.02 (-0.9%)
2.28
+0.08 (+3.64%)
ChartMill assigns a Buy % Consensus number of 100% to ARPO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 47.94. This target is 2079.09% above the current price.
ARPO was analyzed by 2 analysts. The buy percentage consensus is at 100. So analysts seem to be very confident about ARPO.
In the previous month the buy percentage consensus was at a similar level.
Only 2 analysts analyzed ARPO. So this is just the average opinion of a couple of analysts.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-07-08 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
Aerpio Pharmaceuticals Inc / ARPO FAQ
What do analysts expect the price target to be for Aerpio Pharmaceuticals Inc (ARPO)?
2 analysts have analysed ARPO and the average price target is 47.94 null. This implies a price increase of 2079.09% is expected in the next year compared to the current price of 2.2.
What is the consensus rating for ARPO stock?
The consensus rating for Aerpio Pharmaceuticals Inc (ARPO) is 100 / 100 . This indicates that analysts generally have a positive outlook on the stock.